Update on Ankylosing Spondylitis: Current Concepts in Pathogenesis

Overview

Journal Curr Allergy Asthma Rep

Specialties Allergy & Immunology
Pulmonary Medicine

Date 2014 Dec 3

PMID 25447326

Citations 103

Authors

Judith A Smith

Affiliations

Soon will be listed here.

Abstract

Ankylosing spondylitis is an insidiously progressive and debilitating form of arthritis involving the axial skeleton. The long delay in diagnosis and insufficient response to currently available therapeutics both advocate for a greater understanding of disease pathogenesis. Genome-wide association studies of this highly genetic disease have implicated specific immune pathways, including the interleukin (IL)-17/IL-23 pathway, control of nuclear factor kappa B (NF-κB) activation, amino acid trimming for major histocompatibility complex (MHC) antigen presentation, and other genes controlling CD8 and CD4 T cell subsets. The relevance of these pathways has borne out in animal and human subject studies, in particular, the response to novel therapeutic agents. Genetics and the findings of autoantibodies in ankylosing spondylitis revisit the question of autoimmune vs. autoinflammatory etiology. As environmental partners to genetics, recent attention has focused on the roles of microbiota and biomechanical stress in initiating and perpetuating inflammation. Herein, we review these current developments in the investigation of ankylosing spondylitis pathogenesis.

Citing Articles

Promoter Methylation of WIF1 is Involved in IL-17-Induced Chondrocyte Inflammatory Injury and Matrix Degradation via Promoting Wnt5a/MAPK-JNK Signaling.

Chen X, Chen X, Xie J, Guo D Mol Biotechnol. 2025; .

PMID: 40072748 DOI: 10.1007/s12033-025-01378-9.

The harmful effect of ankylosing spondylitis on diabetes mellitus: new evidence from the Mendelian randomization analysis.

Ren Z, He L, Wang J, Shu L, Li C, Ma Y Front Endocrinol (Lausanne). 2024; 15():1369466.

PMID: 39649224 PMC: 11624504. DOI: 10.3389/fendo.2024.1369466.

Association between iridocyclitis and immune-related disease: A 2-sample Mendelian randomization study.

Yao Y, Wang Q, Wei W Medicine (Baltimore). 2024; 103(48):e40663.

PMID: 39612419 PMC: 11608751. DOI: 10.1097/MD.0000000000040663.

Polymorphic variation of the DEFB1 gene might contribute to the development of ankylosing spondylitis: a preliminary study.

Fernandez-Torres J, Zamudio-Cuevas Y, Martinez-Flores K Mol Biol Rep. 2024; 51(1):1051.

PMID: 39395079 DOI: 10.1007/s11033-024-09985-6.

Identification of necroptosis-related genes in ankylosing spondylitis by bioinformatics and experimental validation.

Wen P, Zhao Y, Yang M, Yang P, Nan K, Liu L J Cell Mol Med. 2024; 28(14):e18557.

PMID: 39031474 PMC: 11258886. DOI: 10.1111/jcmm.18557.

References

Visvanathan S, Wagner C, Marini J, Baker D, Gathany T, Han J . Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis. 2007; 67(4):511-7. PMC: 2564765. DOI: 10.1136/ard.2007.071605. View

Jeanty C, Sourisce A, Noteuil A, Jah N, Wielgosik A, Fert I . HLA-B27 subtype oligomerization and intracellular accumulation patterns correlate with predisposition to spondyloarthritis. Arthritis Rheumatol. 2014; 66(8):2113-23. DOI: 10.1002/art.38644. View

Daoussis D, Liossis S, Solomou E, Tsanaktsi A, Bounia K, Karampetsou M . Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2009; 62(1):150-8. DOI: 10.1002/art.27231. View

Rosenbaum J, Lin P, Asquith M, Costello M, Kenna T, Brown M . Does the microbiome play a causal role in spondyloarthritis?. Clin Rheumatol. 2014; 33(6):763-7. DOI: 10.1007/s10067-014-2664-5. View

Taurog J . The role of HLA-B27 in spondyloarthritis. J Rheumatol. 2010; 37(12):2606-16. DOI: 10.3899/jrheum.100889. View

Ciccia F, Accardo-Palumbo A, Rizzo A, Guggino G, Raimondo S, Giardina A . Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann Rheum Dis. 2013; 73(8):1566-74. PMC: 3883901. DOI: 10.1136/annrheumdis-2012-202925. View

Diveu C, McGeachy M, Cua D . Cytokines that regulate autoimmunity. Curr Opin Immunol. 2008; 20(6):663-8. DOI: 10.1016/j.coi.2008.09.003. View

Davidson S, Liu Y, Danoy P, Wu X, Thomas G, Jiang L . Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis. 2010; 70(2):289-92. DOI: 10.1136/ard.2010.133322. View

Reveille J . Genetics of spondyloarthritis--beyond the MHC. Nat Rev Rheumatol. 2012; 8(5):296-304. DOI: 10.1038/nrrheum.2012.41. View

10.

Mielants H, Veys E, Cuvelier C, De Vos M, Botelberghe L . HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. J Rheumatol. 1985; 12(2):294-8. View

11.

Saad C, Ribeiro A, Moraes J, Takayama L, Goncalves C, Rodrigues M . Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?. Arthritis Res Ther. 2012; 14(5):R216. PMC: 3580528. DOI: 10.1186/ar4055. View

12.

Jacques P, Lambrecht S, Verheugen E, Pauwels E, Kollias G, Armaka M . Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2013; 73(2):437-45. DOI: 10.1136/annrheumdis-2013-203643. View

13.

Taurog J, Richardson J, Croft J, Simmons W, Zhou M, Fernandez-Sueiro J . The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994; 180(6):2359-64. PMC: 2191772. DOI: 10.1084/jem.180.6.2359. View

14.

Martinez-Gonzalez O, Cantero-Hinojosa J . Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. Br J Rheumatol. 1994; 33(7):644-7. DOI: 10.1093/rheumatology/33.7.644. View

15.

Lekpa F, Poulain C, Wendling D, Soubrier M, De Bandt M, Berthelot J . Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study. Arthritis Res Ther. 2012; 14(2):R53. PMC: 3446419. DOI: 10.1186/ar3766. View

16.

Kontoyiannis D, Pasparakis M, Pizarro T, Cominelli F, Kollias G . Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999; 10(3):387-98. DOI: 10.1016/s1074-7613(00)80038-2. View

17.

Sarin R, Wu X, Abraham C . Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci U S A. 2011; 108(23):9560-5. PMC: 3111257. DOI: 10.1073/pnas.1017854108. View

18.

Xu H, Chen X, Huang J, Deng W, Zhong Q, Yue C . Identification of GPR65, a novel regulator of matrix metalloproteinases using high through-put screening. Biochem Biophys Res Commun. 2013; 436(1):96-103. DOI: 10.1016/j.bbrc.2013.05.065. View

19.

Noordenbos T, Yeremenko N, Gofita I, van de Sande M, Tak P, Canete J . Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum. 2011; 64(1):99-109. DOI: 10.1002/art.33396. View

20.

Colbert R, Tran T, Layh-Schmitt G . HLA-B27 misfolding and ankylosing spondylitis. Mol Immunol. 2013; 57(1):44-51. PMC: 3857088. DOI: 10.1016/j.molimm.2013.07.013. View